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CFTR functiond by a mutation in the cystic ﬁbrosis transmembrane conductance regulator
(CFTR) gene. In CF, the most common mutant ΔF508-CFTR is misfolded, is retained in the ER and is rapidly
degraded. If conditions could allow ΔF508-CFTR to reach and to stabilize in the plasma membrane, it could
partially correct the CF defect. We have previously shown that annexin V (anxA5) binds to both the normal
CFTR and the ΔF508-CFTR in a Ca2+-dependent manner and that it regulates the chloride channel function of
Wt-CFTR through its membrane integration. Our aim was to extend this ﬁnding to the ΔF508-CFTR. Because
some studies show that thapsigargin (Tg) increases the ΔF508-CFTR apical expression and induces an
increased [Ca2+]i and because anxA5 relocates and binds to the plasma membrane in the presence of Ca2+, we
hypothesized that the Tg effect upon ΔF508-CFTR function could involve anxA5. Our results show that raised
anxA5 expression induces an augmented function of ΔF508-CFTR due to its increased membrane localization.
Furthermore, we show that the Tg effect involves anxA5. Therefore, we suggest that anxA5 is a potential
therapeutic target in CF.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Cystic ﬁbrosis (CF) is themost common severe autosomal recessive
genetic disorder in Caucasians. It is due to a mutation in the gene
encoding the cystic ﬁbrosis transmembrane conductance regulator
(CFTR) [1–3]. The CFTR protein is a cAMP-regulated chloride (Cl−)
channel localized at the apical surface of epithelial cells. It is composed
of two transmembrane segments, two nucleotide-binding domains
(NBDs) and a regulatory domain (R domain) [1]. The R domain
harbours multiple consensus phosphorylation sites by the protein
kinase A (PKA) and the protein kinase C (PKC) [4]. The phosphoryla-
tion of the R domain together with the ATP binding and hydrolysis at
the NBDs regulate the gating of the CFTR channel [4].
CF is caused by a defective Cl− transport in the plasma membrane
of epithelial cells in the lung, pancreas, liver, intestines, sweat duct and
the epididymis [5]. Nevertheless, mutations in the CF gene lead to a
variety of clinical defects, showing that the link between genotype and
phenotype is complex [1,6]. The most common mutation in CFTRlix le Dantec, BP62025, 29220
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l rights reserved.leading to CF is a three-base-pair deletionwhich results in the absence
of a phenylalanine residue at amino acid position 508 (ΔF508) in
NBD1 [7]. The ΔF508-CFTR protein is misfolded [8], retained in the
endoplasmic reticulum (ER) through interactions with the chaperones
and targeted to degradation via the proteasome [7,9]. Indeed, the
misfoldedΔF508-CFTR interacts with the ER chaperones [10,11] which
exhibit an optimal activity when free calcium (Ca2+) concentration is
millimolar. Nevertheless, if some ΔF508-CFTR protein reaches the cell
surface, it exhibits a normal Cl− channel function despite a shorter
half-life than the normal CFTR [11,13]. Therefore, studies were
performed to restore the membrane localization and function of
ΔF508-CFTR [14] using CFTR overexpression [15], low temperature
[16] and chemicals such as glycerol [17], phenylbutyrate [15], genistein
[18] and thapsigargin (Tg) [19]. Tg is a natural tumour-promoting
sesquiterpene lactone which increases the intracellular Ca2+ concen-
tration ([Ca2+]i) in several cell lines by inhibiting the sarcoplasmic or
ER Ca2+-ATPase family SERCA [20]. Therefore, lowering the ER Ca2+
stores induces a decreased retention of ΔF508-CFTR by chaperones
such as calnexin [19]. This decrease in the ER Ca2+ store, which is the
largest Ca2+ store of cells, is accompanied by an increased [Ca2+]i.
We hypothesize that the ΔF508-CFTR function can also be restored
bymodulating its interactingpartners.Nevertheless, the extent towhich
Wt-CFTR and ΔF508-CFTR channels are regulated by protein–protein
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interacting proteins should permit decoding themolecularmechanisms
of the CFTR processing and function and should help to deﬁne new
therapeutic targets to correct the CFTR defects in CF. Several CFTR-
binding proteins are known to modulate the Cl− channel function of
CFTR. SNAP-23 and syntaxin 1A interact with the N-terminus of CFTR
and inhibit its activity [21]. Na+/H+ exchanger regulatory factor (NHERF),
also known as ezrin-binding protein of 50 kDa (EBP-50), and CFTR-
associated protein of 70 kDa (CAP70) interact with the C-terminus CFTR
via their PDZ domains and stimulate the Cl− currents [22–24]. CFTR-
associated ligand (CAL) also binds the C-terminus of CFTR via a PDZ
domain and reduces its apical expression [25]. Recently, we identiﬁed
annexin A5 (anxA5) as a new CFTR partner. We showed that anxA5
interacts with the NBD1 of the Wt-CFTR protein in a Ca2+- and ATP-
dependent manner, as well as with the ΔF508-CFTR [26]. Our previous
study showed that the anxA5 expression is involved in the cAMP-
dependent halide ﬂux through CFTR as well as in its membrane
localization. AnxA5 belongs to the ubiquitous annexin family of Ca2+-
binding proteins [27]. Whereas its role in vivo is still unclear, some of its
properties have been depicted. It interacts with cytoskeletal proteins
[28], exhibits anticoagulant activities [29], inhibits phospholipase A2
[30] and modulates some membrane proteins such as the Na+/Ca2+
exchanger [31]. Furthermore, anxA5 binds to negatively charged
phospholipids in a Ca2+-dependent manner [32], may form a Ca2
+channel [33] and may be involved in exocytosis [34].
Tg restores the ΔF508-CFTR in the membrane as well as its Cl−
channel function in a Ca2+-dependent manner [35] and we previously
showed that anxA5 interacts with Wt-CFTR and ΔF508-CFTR in a Ca2+-
dependentmanner [26]. Therefore,wehypothesized that the effect of Tg
may indirectly involve anxA5 by the increased [Ca2+]i. In the present
paper, we show for the ﬁrst time that anxA5 is involved in the cell
surface localization of theΔF508-CFTR and that the Cl− channel function
of the mutated CFTR is increased when anxA5 is overexpressed.
Furthermore, we show that the Tg effect is decreased when the anxA5
expression is inhibited whereas it is increased when anxA5 is over-
expressed. Therefore, we suggest that the positive effect of Tg involves
anxA5 due to its CFTR-binding properties and to its relocalization to the
membranes in the presence of Ca2+ [32]. Furthermore, we show here
that the single effect of an anxA5 overexpression induces an increased
ΔF508-CFTR function due to an increased localization in the plasma
membrane of polarized and non-polarized cells, likely due to a reduced
recycling. Therefore, we show for the ﬁrst time that the modulation of
anxA5 expression is a potential therapeutic target.
2. Experimental procedures
2.1. Cloning of anxA5 in pcDNA3.1/His
The anxA5 cDNAwas ampliﬁed by PCR using complete cDNA from
HeLa cells as matrix. The primers were: sense 5'-ACCTGAGTAGTCGC-
CATGGCA-3'; anti-sense 5'-CCCCGTGACACGGTCATCTTC-3'. Reactions
were carried out with the following parameters: denaturation at 94 °C
for 15 min, annealing at 62 °C for 30 min and extension at 68 °C for
1.5 min (30 cycles). The PCR products were puriﬁed (Qiaex II, Qiagen,
Germany) and cloned into pcDNA3.1/His (TOPO TA Expression Kit,
Invitrogen, USA). Double-strand sequencing (ABI 310, Applied Biosys-
tems, USA) were performed to ascertain that the ampliﬁcation did not
introduce mistakes and that the coding sequence was in frame.
2.2. Site-directed mutagenesis
Mutagenesis was performed on the cDNA encoding CFTR (Gen-
Bank, M28668) using QuickChange® XL Site-directed Mutagenesis Kit
(Stratagene, USA). The mutated oligonucleotides (Eurobio, France)
corresponding to the ΔF508 mutation were: 5'-CTGGCACCATTAAA-
GAAAATATCGGTGTTTCCTATGATG-3';5'-CATCATAGGAAACACCGATATTTCTTTAATGGTGCCAG-3'. The
mutation was controlled by double-strand sequencing (ABI 310,
Applied Biosystems, USA).
2.3. Expression of short hairpin RNA (shRNA)
To decrease the anxA5 expression, a vector was constructed
according to the Block-it™ RNAi Designer software (Invitrogen, USA).
The single-stranded DNA oligos were: 5'-CACCGAACAAGATGCT-
CAGGCTTTACGAATAAAGCCTGAGCATCTTGTTC-3', 5'-AAAAGAACAA-
GATGCTCAGGCTTTATTCGTAAAGCCTGAGCATCTTGTTC-3'. The
annealing to generate two double-strand oligos and their cloning in
pENTR/U6 were performed with Block-it™ RNAi Entry vector kit,
according to the manufacturer's instructions (Invitrogen, USA). The
provided pENTR/U6/LacZ vector encoding an irrelevant shRNA, was
used as a negative control. Further controls were performed using an
irrelevant scrambled shRNA and with buffer alone (not shown).
2.4. Cell culture and transfection
A549 cells, an immortalized human airwayepithelial cell line (ATCC
CCL-185, UK), were cultured in F-12Kmedium supplementedwith 10%
foetal bovine serum (FBS) and 100 U/ml penicillin–streptomycin in a
humidiﬁed CO2 incubator (37 °C). They were transfected by Lipofecta-
mine 2000 (Invitrogen, USA) with the pcDNA3.1 containing either the
Wt-CFTR or the ΔF508-CFTR cDNA. Stably transfected cells were
selected by neomycin. CFTR expressionwas assessed after 10 passages.
Later, the cellswere transfectedwith pcDNA3.1/anxA5 encoding anxA5
or with the shRNA against anxA5 (pENTR/U6/anxA5). AnxA5 expres-
sion was assessed by Western blotting as described below and
compared with the negative controls. In some experiments, cells
were treated with 500 nM Tg (16 h, 37 °C) [36].
Immortalized normal (16HBE14o−) and CF (CFBE41o−) polarized
airway epithelial cell lines were from Pr D.C. Gruenert (University of
California, San Francisco). The CFBE41o− cells are homozygous for the
delF508 mutation whereas the 16HBE14o− cells have the character-
istics of superﬁcial epithelial cells and were originally derived by viral
transformation of cells dissociated from human bronchial epithelium
[37,38]. The cells were cultured in Eagle's minimal essential medium
(MEM) supplemented with 10% FBS and glutamine on an extracellular
matrix (CellBind Corning, Bioblock).
2.5. Immunoﬂuorescent labelling of CFTR after modulation of the anxA5
expression in cells with and without Tg treatment
Cells were grown on 22×22 mm glass coverslips and ﬁxed in
phosphate-buffered saline (PBS) containing 4% paraformaldehyde (w/
v) for 30 min at room temperature (RT). The cells were permeabilized
(0.25% saponin, 45 min, RT) and saturated (3% bovine serum albumin,
(1 h, RT). Immunoﬂuorescencewas performed using successively anti-
CFTR rabbit polyclonal antibodies (7.5 μg/ml; PA1-935, ABR, BD
Bioscience Pharmingen, USA) for 1.5 h and goat anti-rabbit second
antibodies coupled to Texas Red (1:250; GeneTex, Inc., USA) for 1 h.
Nuclei were stained with DAPI. Actin cytoskeleton was labelled with
phalloidin-FluoProbes®547 (1/40, Molecular Probes) according to the
manufacturer's instructions.
2.6. Western blot analysis
Cells were lysed (50 mM Tris HCl, pH 6.8, 100 mMNaCl, 1% Triton X-
100 and protease inhibitor cocktail [Sigma]) and protein concentrations
were determined using the Lowry procedure [39]. The samples were
resolved by SDS-PAGE (7.5%) and transferred on a PVDF membrane
(Amersham Biosciences, UK). CFTR was detected by successive incuba-
tion of the membranes with a mouse monoclonal antibody anti-CFTR
(1:500, Ab-2 (MM13-4), Interchim, France) and a peroxidase labelled
Fig. 1. anxA5 expression in non-polarized (A549) and polarized ΔF508-CFTR-expressing cells (CFBE41o−). The left panel shows an example of western blot representing the
expression of anxA5 (35 kDa) in wt-CFTR- and ΔF508-CFTR A549 cells (1 and 2, respectively), in 16HBE14o− (3) and CFBE41o− (4) cells. The right panel shows the corresponding
quantiﬁcation (percentage). The anxA5 levels tended to be lower in ΔF508-CFTR-expressing cells.
Fig. 2. Co-immunoprecipitation of anxA5 with Wt-CFTR and ΔF508-CFTR. CFTR protein
was immunoprecipitated from Wt-CFTR- and ΔF508-CFTR-expressing A549 cells. The
complexes were resolved by SDS/PAGE (12%) and transferred onto a PVDF membrane.
AnxA5 was then detected by immunoblotting and was observed in the complexes. It
was not detected in the complex from A549 cells which did not express CFTR (NT) or
when an irrelevant antibody was linked on the beads (negative control). Pure anxA5
was used as molecular weight control (35 kDa).
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detected bywestern blotting (12%) using a goat polyclonal IgG (sc-1929;
Santa Cruz Biotechnology, USA) and a peroxidase anti-goat antibody
(Sigma, France). Immunoreactive proteins were visualised by enhanced
chemiluminescence (ECL+, Amersham Bioscience, UK). Densitometric
analysis of the ﬁlms was performed using a Biovision 1000 apparatus
(Fischer Bioblock) and each valuewas normalized to the total amount of
loaded proteins per lane as well as by G3PDH and actin quantiﬁcations
(MAb to Glyceraldehyde-3-PDH (Biodesin International)). Actin expres-
sion was assessed by Western blotting (12%) using anti-nonmuscle-F-
actin (1/200, Santa Cruz Biotechnology).
2.7. Immunoprecipitation
Wt-CFTR-anxA5 and ΔF508-CFTR-anxA5 interactions were pre-
viously demonstrated [26]. The effect of the ΔF508 mutation upon the
interaction was studied here by co-immunoprecipitation. Total protein
was extracted fromWt-CFTR- andΔF508-CFTR-expressing cells (50mM
Tris HCl, pH 6.8, 100 mM NaCl, 1% Triton X-100 and protease inhibitor
cocktail). The anti-CFTR antibody (Ab-2 (MM13-4), Interchim, France)
was coupled to Dynabeads Protein G (Dynal Biotech, Invitrogen, USA)
overnight at 4 °C with rotation. After centrifugation (6000 g, 15 min),
clariﬁed cell lysates were incubated with the beads. After incubation
(16 h, 4 °C), the beads were washed four times in PBS and samples were
resolved by SDS-PAGE (12%). AnxA5 was detected with the anti-anxA5
antibody. The commercially available puriﬁed anxA5 was used as
molecularweight control (35 kDa). The negative controlswere obtained
with cells which did not express CFTR and using an irrelevant antibody
(anti-V5 antibody, Invitrogen, USA) coupled to the beads.
2.8. Measurement Fura 2-AM
To ensure that the Tg treatment induced an increased [Ca2+]i, Wt-
CFTR- and ΔF508-CFTR-expressing cells were loaded for 45 min with
2 μM Ca2+-sensitive ﬂuorescent probe fura-2 acetoxy-methyl ester
(Fura-2 AM, Invitrogen Molecular Probes, USA) at RT in the dark. Cells
were rinsed twice and incubated in Tyrode solution (20 min, 37 °C).
Fluorescence was recorded at 340 nm (saturated Ca2+) and 380 nm
(free Ca2+) andwas analysed using Fluostar software (IMSTAR, France).
For each experiment, 20–30 cells were observed and the responses
were compared with the controls obtained with untransfected cells or
with cells that were not treated with Tg.
2.9. Methoxy-N-(3-sulfopropyl)quinolinium (SPQ) ﬂuorescence assay
The cAMP-dependent halide ﬂux throughWt-CFTR andΔF508-CFTR
wasassessedbySPQassaysusing forskolin as aCFTRactivator. Cellswere
loaded with 10 mM SPQ (Molecular Probes) and placed in a quenching
NaI buffer. The baseline ﬂuorescence was measured in isotonic NaI
buffer and cells were then perfused with isotonic dequench buffer(NaNO3 replaced NaI). The perfusate was then switched to dequench
buffer plus agonist and requenched at the end of the experiments. An
inverted microscope equipped for ﬂuorescence (IX-71, Olympus) was
used and illuminationwas performed at 360 nm. The emitted light was
collected at 456±33 nm by a high-resolution image intensiﬁer coupled
to a video camera connected to a digital image processing board (FLUO
software, Imstar, France). During the experiments (n=5) the cell
morphology and number were checked to ensure that there was no
difference due to the siRNA. SPQ experiments were also performed
when anxA5 was overexpressed in cells transfected or not with the
cDNA encoding CFTR. The controls were performed using cells
transfected with the empty pcDNA3.1 vector. For the statistical analysis
[40,41], ﬂuorescence intensity was standardized according to the
equation F=(F−Fo)/Fo×100, where F is the relative ﬂuorescence and
Fo, the ﬂuorescence intensity measured in presence of I−. The halides
membrane permeability (P) was determined as the rate of SPQ
dequenching upon perfusion with nitrates. At least three successive
data points were collected immediately after the NO3− containing
medium application, and then ﬁtted using a linear regression analysis.
The slope of the straight line reﬂecting the membrane permeability to
halides (noted P in min−1) was used as an index of CFTR activity.
2.10. Patch clamp
A patch-clamp techniquewas used to record themembrane currents
under voltage clamped conditions [42]. The measurements of ionic
currentsweremade by using a patch-clamp ampliﬁer (Geneclamp 500B,
Axon, USA) equippedwith a current to voltage converter headstage (CV5
series). The signals were recorded with a micro-computer via an
analogue to digital converter (CED 1401 plus, UK) running at 35 kHz.
TheWCPv. 3.5.9 program (StrathclydeUniversity, UK)wasused to record
the currents and to deliver programmed voltage pulses. The stimulating
pulses (−50 to 200mVby 10mVsteps, duration 200ms)were applied to
the patch from theholdingpotential. The currentswere analysed off-line
with WCP and conductances were calculated from the slope of the
current–potential relationship.
Fig. 3.Modulation of anxA5 expression in A549 cells. Example of detection of anxA5 in
Wt-CFTR- and ΔF508-CFTR-expressing A549 cells byWestern blotting. (A)Wt-CFTR and
ΔF508-CFTR-expressing A549 cells were transfected with either the shRNA directed
against anxA5 or the irrelevant shRNA. Decreased anxA5 expression was observed in
both cell types in the presence of its speciﬁc shRNA, when compared to the control
(upper panel). Overexpression of anxA5 was obtained in Wt-CFTR and ΔF508-CFTR-
expressing-A549 cells by transfection with the cDNA encoding anxA5 (lower panel).
48 h after the transfection, anxA5 expression was increased in both cell types when
compared with the control (empty pcDNA3.1 vector). (B) Representative histograms
(percentage) showing the statistical decreased anxA5 expression due to the shRNA and
its signiﬁcant increase in transfected cells. (⁎⁎⁎: pb0.001).
Fig. 4. Effect of the modulation of anxA5 expression upon the cAMP-dependent halide
ﬂux through ΔF508-CFTR in A549 cells. Bar graph representation of the effect of the
decreased and increased anxA5 expression upon the cAMP-dependent halide ﬂux
through ΔF508-CFTR in A549 cells channel which was measured by ﬂuorescence digital
imaging microscopy using SPQ dye. The obtained curves were used to determine the
halide permeability (P) as the rate of SPQ dequenching in NO3− medium under baseline
conditions and under cAMP stimulation. When anxA5 expression was decreased the
cAMP-dependent halide ﬂux through ΔF508-CFTR in A549 cells was signiﬁcantly
decreased when compared to the control (light grey). When anxA5 was overexpressed,
the halide ﬂux was signiﬁcantly increased (dark grey). Comparison with non-treated
ΔF508-CFTR-expressing A549 cells (white) indicate that the controls did not modify the
halide ﬂux. Bars represent SEM, ⁎: pb0.05, ⁎⁎: pb0.001.
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with 500 nM Tg (16 h, 37 °C). In all experiments, cells were pre-treated
with bumetamide as described above. In order to assess the CFTR
activity in electrophysiological recordings, glibenclamide was used to
block CFTR activity (data not shown).
2.11. Cell surface expression of CFTR by biotinylation
To estimate the CFTR (Wt and ΔF508) presence in the plasma
membranes of the cells after modulation of anxA5 expression, coupled
or not to a Tg treatment, the membrane proteins were biotinylated as
previously described [43,44]. Brieﬂy, conﬂuent cells were washed with
ice-cold PBS (pH 8.0), incubated in Sulfo-NHS-SS-Biotin solution
(Pinpoint™ Cell Surface Protein Isolation Kit, Pierce, USA) for 30 min at
4 °C and quenching solution was added. Cells were scraped and
centrifuged (3 min, 500 g). The pellets were suspended in lysis buffer
(Tris–HCl pH 6.8, 50 mM; NaCl 100 mM; Triton X-100 2% and
antiprotease cocktail) and incubated for 30 min on ice. Cell lysates
were clariﬁed (2 min, 10,000 g, 4 °C) and biotinylated proteins were
isolated on Immobilized NeutrAvidin™ gel according to the manufac-turer's instructions (Pierce, USA). The CFTR proteinwas further detected
by Western blotting as described above.
2.12. Statistical analysis
Student's t-test was used and differences were considered
signiﬁcant when pb0.05 (⁎) and very signiﬁcant when pb0.001 (⁎⁎).
3. Results
3.1. AnxA5 expression in non-polarized (A549) and polarized ΔF508-
CFTR-expressing cells (CFBE41o−)
The basal anxA5 expression was assessed in A549 and in CFBE41o−
cells bywestern blots. As shown in Fig.1, anxA5 expressionwas higher in
polarized cells than innon-polarized cells. Although itwasnot signiﬁcant,
this expression tended to be lower in ΔF508-CFTR-expressing cells.
3.2. The ΔF508 mutation does not disrupt the CFTR–anxA5 interaction
We previously showed direct anxA5–CFTR and anxA5–ΔF508-
CFTR interactions [26]. Nevertheless, the presence of anxA5 in Wt-
CFTR and in the ΔF508-CFTR protein complex was assessed here by
co-immunoprecipitation. As shown in Fig. 2, anxA5 was present in the
immunoprecipitated complexes from Wt-CFTR- and ΔF508-CFTR-
expressing A549 cells, whereas it was not detected in the A549 cells
which were not transfected with the cDNA encoding for the CFTR
protein (NT) or when an irrelevant antibody was linked to the beads.
This result indicated that the ΔF508 mutation did not disrupt the
interaction. Pure anxA5 protein was used as molecular weight control
to ensure the molecular weight of the observed bands.
3.3. Modulation of the anxA5 expression in Wt-CFTR- and ΔF508-CFTR-
expressing A549 cells
To decrease the anxA5 expression, Wt-CFTR- and ΔF508-CFTR-
expressing A549 cells were transfected with either the shRNA directed
against anxA5 or the control shRNA. After the transfection (48 h),
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panel). AnxA5 overexpressionwas obtained after transfectionwith the
cDNA encoding anxA5 (pcDNA3.1/anxA5, Fig. 3A, lower panel). The
pcDNA3.1 empty vector was used as a negative control. AnxA5
expression was assessed at increasing time points after the transfec-
tion (not shown), and peaked 48 h after transfection. In all type of
experiments, actin was used as a reference gene (Fig. 3A). The
statistical analysis was performed (Fig. 3B). AnxA5 expression was
decreased in the presence of the shRNA by 73.5±1.1% (n=3) and 75.6
±1.8% (n=3) in Wt-CFTR- and ΔF508-CFTR-expressing cells, respec-
tively, when compared to the controls. Its expressionwas increased in
the presence of the cDNA encoding anxA5 by 69.8±0.8% and 71.4
±1.2% in Wt-CFTR- and ΔF508-CFTR-A549 expressing cells, respec-
tively, when compared to the controls.
Because anxA5 is an actin-binding protein and because actin is
involved in CFTR function, actin expression was studied. Actin
expression was not modiﬁed in Wt-CFTR- or ΔF508-CFTR-expressing
cells when anxA5 expression was modulated (not shown).
3.4. The cAMP-dependent halide ﬂux through ΔF508-CFTR depends on
anxA5 expression in A549 cells
We previously showed that the cAMP-dependent halide ﬂux
through Wt-CFTR was correlated with anxA5 expression in A549 cells
[26]. Therefore, we investigated the cAMP-dependent halide ﬂuxFig. 5. Study of the effect of Tg in Wt-CFTR- and ΔF508-CFTR-expressing A549 cells. (A) The e
cells, Wt-CFTR- and ΔF508-CFTR-expressing A549 cells were loaded with Fura-2 AM after Tg
and 380 nm (free calcium) and compared with that of untreated cells. In all cell types, Tg ind
the Cl− channel function of Wt-CFTR and ΔF508-CFTR was measured by patch-clamp. Th
increased CFTR channel function. Cells which did not express CFTR and untreated cells w
expression in Wt-CFTR- and ΔF508-CFTR-expressing A549 cells by Western blotting. Tg trea
was loaded in each lane (50 μg).through ΔF508-CFTR when anxA5 expression was decreased and
increased. Halide permeability was measured using the SPQ dye 48 h
after the transfection with pENTR/U6/anxA5 or with the irrelevant
shRNA. The curves obtained after cAMP stimulation of the CFTR
channel and the blockage of other Cl− channels showed a residual
function of ΔF508-CFTR, as previously described [12]. Statistical
analysis of the experiments (Fig. 4) indicated that the shRNA induced
a signiﬁcant decreased halide ﬂux through ΔF508-CFTR in A549 cells
when compared to the negative controls performed with the
irrelevant shRNA which had no effect by itself.
The overexpression of anxA5 induced a very signiﬁcant increased
cAMP-dependent halide ﬂux through ΔF508-CFTR in A549 cells (Fig.
4). In the controls performed with cells which did not express CFTR
(not shown) and with the empty vector, no modiﬁcation of the halide
ﬂuxwas observed. Therefore, our results indicate for the ﬁrst time that
the cAMP-dependent halide ﬂux through ΔF508 CFTR is correlated
with anxA5 expression.
3.5. Tg treatment increases Wt and ΔF508-CFTR channel activity
It was previously shown that Tg increases the cell surface
expression of ΔF508-CFTR due to the decreased ER Ca2+ store affecting
the calnexin–CFTR interaction [35]. In a previous study, we demon-
strated that the anxA5–CFTR interaction is Ca2+-dependent [26]. These
data, together with the known anxA5 relocalization in the membraneffect of Tg upon [Ca2+]i was checked by Fura 2-AMmeasurement. Non-transfected A549
treatment. For each cell type, ﬂuorescence was recorded at 340 nm (saturated calcium)
uced a signiﬁcant increase in [Ca2+]i. Bars represent SEM (n=5). (B) The effect of Tg upon
e I/V relationships show that in both Wt-CFTR- and ΔF508-CFTR-expressing cells, Tg
ere used as negative controls. Bars represent SEM. (C) Analysis of Tg effect on anxA5
tment did not modify anxA5 expression in either cell type. The same amount of protein
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[Ca2+]i could increase the Cl− channel activities of CFTR. To test this
hypothesis, we studied the CFTR channel activity in A549 cells when
anxA5 expressionwasmodulated in the presence or absence of Tg. We
ﬁrst checked that [Ca2+]i was increased in our cell model after Tg
treatment (16 h) using Fura 2-AM. As shown in Fig. 5A, a signiﬁcant
increase in [Ca2+]i caused by Tg was observed in the A549 cells
expressing the Wt-CFTR (+29.3±1.8%) or the ΔF508-CFTR (+32±1.2%)
protein, when compared with untreated cells.
The Cl− channel activity of CFTR was measured by patch-clamp in
Wt-CFTR- and ΔF508-CFTR-expressing A549 cells after Tg treatment.
Untransfected and untreated A549 cells were used as negative
controls (not shown). As shown in Fig. 5B, the I/V relationship
obtained indicates that the Cl− channel function of both the Wt-CFTR
and the ΔF508-CFTR was increased in the presence of Tg in A549 cells.Fig. 6. Cell-attached patch-clamp experiments performed in ΔF508-CFTR-expressing A549 c
treatment. (A) The upper panel indicates the cell conditions used in the patch-clamp analysis.
representative of the currents recorded in ΔF508-CFTR before (basal currents) and after cAMP
The lower trace represents the voltage steps applied to the membrane. Horizontal bar, 20.88
conditions (mean±SEM). Bar graphs represent the statistical analysis of the current amplitu
only forskolin and IBMX were applied to the cells were taken as reference for the analysis.This result was in accordance with previous results [19,35]. As shown
in Fig. 5C, Tg had no effect upon anxA5 expression, which could have
explained the increased Cl− channel activity of both Wt-CFTR and
ΔF508-CFTR in this cell types.
3.6. AnxA5 overexpression enhances the Tg effect in ΔF508-CFTR-
expressing A549 cells
The combined effect of Tg andmodulation of anxA5 expressionwas
studied in the ΔF508-CFTR-expressing A549 cells. In a ﬁrst set of
experiments, we found that Tg treatment, shRNA and anxA5 over-
expression had no effect upon Cl− ﬂux in the cells that did not express
the CFTR protein (not shown).
The Cl− channel activity of CFTR was assessed by the cell-attached
patch-clamp technique. Fig. 6A shows the experimental conditionsells submitted to different levels of anxA5 expression in native conditions and after Tg
The upper waveforms trace currents recorded in each set of experimental conditions are
stimulation underexpressing or overexpressing anxA5 with or without Tg in A549 cells.
ms; vertical bars, 1 nA (top) and 1 mV (bottom). (B) I/V relationship in all experimental
des (mean±SEM, n=5) at +60 mV in all experimental conditions. The conditions where
⁎: pb0.05, ⁎⁎: pb0.01, ⁎⁎⁎: pb0.001.
Fig. 8. Cell surface detection of Wt-CFTR and ΔF508-CFTR by biotinylation, when anxA5
expression is reduced. When both Wt-CFTR- and ΔF508-CFTR-expressing A549 cells
were transfected by the irrelevant shRNA, cell surface expression of CFTR protein was
detected in membrane proteins after biotinylation and Western blotting. CFTR was not
detected in membrane proteins from non-transfected cells (negative control). The
plasma membrane expression of Wt-CFTR and ΔF508-CFTR in A549 cells was observed
when the irrelevant shRNA was transfected, whereas neither protein was detected
when anxA5 expression was reduced. The same amount of protein was loaded in each
lane.
Fig. 7. Cell surfacedetectionofWt-CFTRandΔF508-CFTRbybiotinylation inA549cells. Cell
surface proteins of the cells expressing Wt-CFTR or ΔF508-CFTR were labelled by
biotinylation, puriﬁed and analysed by Western blotting (7% gel electrophoresis). The
mature CFTR (170 kDa) band is observed and is stronger inWt-CFTR-expressing A549 cells
than in ΔF508-CFTR A549 cells. Non-transfected A549 cells which do not express CFTR
were used as negative controls and the same amount of protein was loaded in each lane.
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recordings showed that the forskolin treatment stimulated the
ΔF508-CFTR Cl− channel activity. The response of ΔF508-CFTR
channels to the stimulation was lower than that of Wt-CFTR (not
shown). These results can be correlated with those obtained in SPQ
experiments. The patch-clamp recordings were converted to current–
potential (I/V) relationship representations (Fig. 6B). When anxA5
expression was reduced in A549 cells the slope of the curves was
decreased, indicating a reduced channel activity of ΔF508-CFTR.
Conversely, the slopes of the curves were increased when anxA5 was
overexpressed or when cells were treated with Tg. Finally, the slopes
of the curves were increased when anxA5 was overexpressed in
Tg-treated cells when compared with those of cells only submitted
to Tg treatment or to anxA5 overexpression alone. The lower panel in
Fig. 6B represents the current amplitudes (at +60 mV) and highlights
statistical differences. The results show that the anxA5 expression
reduced by shRNA signiﬁcantly decreased the channel activities of the
ΔF508-CFTR which function was signiﬁcantly enhanced when anxA5
was overexpressed. It was further increased when anxA5 over-
expressionwas coupled to the Tg treatment, when compared with the
effect of each treatment singly applied. For each experiment, controls
were performed with the irrelevant shRNA, with the empty vector
and with non-transfected cells (not shown).
In conclusion, these experiments show for the ﬁrst time that anxA5
protein is intimately involved in the Cl− channel function of ΔF508-
CFTR. Finally, we demonstrate here that increasing anxA5 expression
improved the effect of Tg upon the ΔF508-CFTR channel activity.
3.7. AnxA5 overexpression enhances the cell surface expression of both
Wt-CFTR and ΔF508-CFTR
To determine whether the increased Cl− currents were due to an
increased channel activity or to an increased cell surface expression of
the CFTR protein, the cell surface localization of the ΔF508-CFTR
proteins was analysed by immunoﬂuorescence studies (not shown)
and by cell surface biotinylation experiments [43,44].
In immunoﬂuorescence experiments we observed that the
irrelevant shRNA had no effect upon the ΔF508-CFTR localization
whereas the shRNA directed against anxA5 induced its decreased
membrane localization (not shown). We conﬁrmed that Tg increases
the cell surface expression of the ΔF508-CFTR [19] and showed that
this positive effect was conserved when anxA5 expression was
reduced.
When anxA5 was overexpressed, with or without Tg, ΔF508-CFTR
localization was increased in the cell membrane. AnxA5 modulation
had no effect upon actin distribution.
We conﬁrmed these results by biochemical assays. The total cell
surface proteins were biotinylated, puriﬁed on a streptavidin column
and the CFTR protein was detected in collected fractions by Western
blotting. As shown in Fig. 7, CFTR was observed in the membrane in
the Wt-CFTR-expressing A549 cells, whereas a faint band was
observed in the membrane proteins from the ΔF508-CFTR-expressing
A549 cells, consistent with the retention and degradation of most ofthe mutated protein in the ER. The effect of the decreased anxA5
expression on the cell surface expression of CFTR in Wt-CFTR- and
ΔF508-CFTR-expressing cells was assessed. When anxA5 expression
was decreased, membrane expression of both Wt-CFTR and ΔF508-
CFTR proteins was inhibited (Fig. 8).
Wt-CFTR and ΔF508-CFTR membrane localization was further
studied when anxA5 was overexpressed in A549 cells. As shown
in Fig. 9, a faint band was observed in Wt-CFTR- and ΔF508-CFTR-
expressing cells after transfection with the empty vector used as
control. These bands were stronger when anxA5 was overexpressed.
Therefore, anxA5 overexpression increased the cell surface expres-
sion of both Wt-CFTR and ΔF508-CFTR proteins. This cell surface
expression of both Wt-CFTR and ΔF508-CFTR was increased when
anxA5-overexpressing cells were treated with Tg. In summary, the
cell surface expression of Wt-CFTR and ΔF508-CFTR proteins was
decreased in the absence of anxA5 expression and, conversely, was
increased when anxA5 protein was overexpressed and Tg enhanced
the ΔF508-CFTR expression in plasma membrane in anxA5-over-
expressing A549 cells.
3.8. Modulation of anxA5 expression in polarized cells
Our results were extended in the polarized cell line CFBE41o− in
which anxA5 expression was modulated. As shown in Fig. 10A, shRNA
induced a signiﬁcant anxA5 decreased expression whereas a sig-
niﬁcant anxA5 overexpression was observed in the presence of the
cDNA encoding anxA5. SPQ experiments were performed in the
CFBE41o− cells when anxA5 expression was modulated. As shown in
Fig. 10B, the cAMP-dependent halide ﬂux was signiﬁcantly decreased
when anxA5 expression was inhibited. The anxA5 overexpression
induced signiﬁcant increased cAMP-dependent halide ﬂux in CFBE41o
− cells. Therefore, the results were similar in non-polarized and in
polarized cells. Biotinylation experiments performed in the CFBE41o−
cells overexpressing anxA5 indicated that the increased cAMP-
dependent halide ﬂux was likely due to an increased ΔF508-CFTR
localization in the apical membranes in these polarized cells (Fig. 10C,
left panel). Immunolocalization of the CFTR protein was performed in
the CFBE41o− cells when anxA5 expression was increased (Fig. 10C,
right panel). A faint increased localization of the mutated CFTR in the
plasma membrane was observed when compared with cells trans-
fected with the empty vector. Therefore immunoﬂuorescence was in
accordance with the biotinylation experiments.
4. Discussion
The proteins or drugs that might increase the cell surface
expression of the ΔF508-CFTR are potential targets to correct the Cl−
Fig. 10.Modulation of anxA5 expression inpolarized cells (CFBE41o−). (A) Example ofwestern blot (left panel) performed to assess the expression of actin and anxA5 in 16HBE14o− (1) and
in CFBE41o− cells (2–5). CFBE41o− cellswere transfectedwith either the control shRNA (2), the shRNAdirected against anxA5 (3), the control plasmid (4) and the cDNAencoding anxA5 (5).
The anxA5 expressionwas quantiﬁed (right panel) showing that the shRNA induced a signiﬁcant anxA5 decreased expressionwhereas a signiﬁcant anxA5 overexpressionwas observed in
the presence of the cDNA encoding anxA5. (B) SPQ experiments were performed in CFBE41o− cells and P (min−1) was calculated as described above. The cAMP-dependent halide ﬂuxwas
signiﬁcantly decreasedwhen anxA5 expressionwas inhibited and itwas increasedwhen anxA5was overexpressed. (C) Biotinylation experiments were performed as described above and
CFTRwas detectedby immunoblotting. In CFBE41o− cells transfectedwith the control cDNA, theCFTRproteinwasnot distinguished (1)whereas itwas observed in the cells overexpressing
anxA5 (2). Immunoﬂuorescencewasperformed inCFBE41o−. In theCFBE41o− cellswhichwere transfectedwith theemptyvector, CFTRwasobservedmainlyaround thenuclei (left image).
In the CFBE41o− cells which were transfected with the cDNA encoding anxA5, a faint labelling in the membrane was observed (right image).
Fig. 9. Cell surface detection of Wt-CFTR and ΔF508-CFTR in A549 cells by biotinylation, when anxA5 is overexpressed, with and without Tg. Biotinylation experiments and CFTR
detectionwere performed.When anxA5 is overexpressed, bothWt-CFTR and ΔF508-CFTR are detected inmembrane proteins at a higher level when comparedwith the empty vector
transfected cells. The cell surface expression of Wt-CFTR and ΔF508-CFTR in A549 cells is further increased in the presence of Tg. A549 cells which did not express the CFTR proteins
(NT) were used as a negative controls.
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because annexin 2 belongs to the functional complex of CFTR [46], and
because anxA5 is overexpressed in CF epithelial cells from foetal
trachea [47], annexins are involved in CF. In a previous study we
identiﬁed anxA5 as a Ca2+-dependent partner of CFTR whose
expression was necessary for the CFTR membrane localization and
channel function [26]. This led us to investigate whether anxA5 has
any effect upon ΔF508 function or membrane localization.
The present study was performed in A549 cells, an immortalized
human airway epithelial cell line which is routinely used as a model of
pulmonary epithelium despite they are not polarized [26,48]. The cells
were stably transfected with the cDNA encoding the Wt-CFTR or
ΔF508-CFTR proteins. Functional studies, immunoﬂuorescent label-
ling and biotinylation assays showed that the Wt-CFTR was functional
at the cell surface, whereas a small fraction of functional ΔF508-CFTR
channels reached the cell surface, according to the previously
described cell model [26].
Because anxA5 expression is necessary for CFTR function and
because anxA5 interacts with the both the normal and mutated CFTR,
we hypothesized that anxA5 could also regulate the function and
membrane localization of ΔF508-CFTR. To test this hypothesis, we
modulated anxA5 expression in both Wt-CFTR- and ΔF508-CFTR-
expressing cells. The results showed that the decreased anxA5
expression reduced the Cl− channel activities of both Wt and ΔF508-
CFTR channels whereas they were increased when anxA5 was
overexpressed. Nevertheless, these experiments did not show
whether anxA5 regulates the channel activity or the plasma
membrane expression of CFTR. Therefore, its cell surface expression
was analysed. Our results show that anxA5 underexpression decreases
the cell surface localization of both normal and mutated channels and
that its overexpression increases it, suggesting that the membrane
expression of CFTR in polarized and non-polarized cells depends on
anxA5 expression. These data led us to hypothesize that anxA5 might
be involved in the regulation of the CFTR trafﬁcking or in its stability in
the plasma membrane. Indeed, annexins are involved in membrane
organization, membrane trafﬁcking and membrane-cytoskeleton-
linkage [49]. Furthermore, the main property of anxA5 is to bind to
negatively charged phospholipids of the plasma membrane and to the
membranes of the biosynthetic or endocytic pathway, in a Ca2+-
dependent manner [32]. Therefore, because anxA5 binds to both Wt
and ΔF508-CFTR and increases their cell surface expression and
because annexins are involved in membrane trafﬁcking, we hypothe-
size that anxA5 might regulate CFTR trafﬁcking to the cell surface.
Because anxA5 is a non-membrane-aggregating annexin [50], we
speculate that it is involved in the stability of CFTR in the plasma
membrane rather than in the trafﬁcking process. Moreover, because
anxA5 is involved in the stabilization of the membranes [51], because
it binds to the membranes and to actin, because it regulates the
function and the distribution of membrane glycoproteins [52] and
because CFTR binds to actin [53], we suggest that anxA5 belongs to the
three-dimensional network that might stabilize the mutated CFTR at
the cell surface increasing its half-life in the plasma membrane. This
could explain why the cell surface expression of both Wt-CFTR and
ΔF508-CFTR depends on anxA5 expression. The ﬁndings that
increased anxA5 expression leads to the transport of ΔF508-CFTR to
the plasmamembrane seem in contradictionwith the results showing
an increased anxA5 expression in fetal CF cells. Nevertheless, the
expression of CFTR-speciﬁc mRNA is approximately 75-fold greater in
the fetal lung than in the adult lung and anxA5 accumulates almost
linearly from birth to adulthood. Because anxA5 expression tends to
be higher in CF cells, our hypothesis that it may in act upon the
constitutive internalization and recycling of CFTR.
Since the anxA5–CFTR interaction and the anxA5 relocalization to
the plasma membrane both depend on [Ca2+]i, we hypothesized that
increasing the [Ca2+]i might help to maintain the cell surface
expression of both Wt and ΔF508-CFTR. This was tested using Tg,the most widely used SERCA inhibitor, which increases the [Ca2+]i by
mobilizing the sequestered ER calcium stores. Furthermore, Tg
induced the redistribution of the ΔF508-CFTR from the ER to the
apical membrane [19,35] by disrupting the interaction between the
newly synthesized CFTR and calnexin, a Ca2+-dependent chaperone
protein involved in ΔF508-CFTR retention in the ER. We suggest that
anxA5 could be involved in the positive effect of Tg hitherto only
attributed to the disruption of the calnexin–ΔF508-CFTR interaction.
In the present study, we demonstrate that Tg increases the cell
surface expression of both Wt and the mutated CFTR in A549 cells.
However, this effect was decreased when anxA5 expression was
reduced, but was not totally abolished. This indicates that the positive
effect of Tg involves anxA5. Because Tg does not induce increased
anxA5 expression, this effect is likely due to the previously described
relocalization of anxA5 to the membrane when [Ca2+]i is increased.
In conclusion, because anxA5–CFTR, anxA5–membrane and
anxA5–actin interactions are regulated by [Ca2+]i, we suggest that
the increased [Ca2+]i induced by Tg might enhance the formation of
the three-dimensional network. So, enhancement of anxA5 expres-
sion may increase the presence of the mutated CFTR protein in the
plasma membrane where it exhibits some Cl− channel functions.
This study shows for the ﬁrst time that anxA5, which interacts with
the NBD1 of the CFTR [26], regulates the cell surface expression of
both theWt and the mutated CFTR by increasing their presence in the
plasma membrane in polarized and in non-polarized cells. We show
that an increased [Ca2+]i induces an increased anxA5 effect upon CFTR
function. Therefore we propose a synergic and Ca2+-dependent effect
between Tg and anxA5. This positive effect of anxA5 has now to be
taken into account when drugs such as Tg are used in order to restore
the function of a mutated protein which is released from the ER.
Furthermore, we propose that increased anxA5 expression in vivo
might partially correct the altered Cl− channel in CF.
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